Vital Labs

The company is developing the VitalOne, a machine designed for point-of-care use in doctors' offices. This device aims to process up to 50 different blood tests from a small sample, delivering results within 20 minutes. This contrasts sharply with the conventional model that often requires sending samples to large, centralized labs, which can take several days to return results. The business serves primary care physicians, urgent care clinics, and other healthcare providers who require rapid and comprehensive diagnostic information to make timely clinical decisions.

The core of Vital's product is a platform that combines robotics, biochemistry, and AI to perform three common types of lab tests: hematology, clinical chemistry, and immunoassays, all on a single device. By placing this technology directly at the point of care, Vital aims to eliminate the delays and patient disempowerment associated with centralized lab testing. Their strategy involves building robust platform approaches, enabling them to add new tests more efficiently than traditional methods. The company has cultivated trust within the industry, notably having LabCorp as an investor.